Alexander V Kabanov Selected Research

Copper

1/2019	Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue.
1/2016	Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesity.
1/2016	Nanoformulated copper/zinc superoxide dismutase reduces adipose inflammation in obesity.
8/2014	Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander V Kabanov Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 08/2002
13	Parkinson Disease (Parkinson's Disease) 03/2022 - 09/2007
11	Inflammation (Inflammations) 04/2021 - 12/2006
9	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2005
6	Obesity 04/2022 - 04/2010
6	Carcinoma (Carcinomatosis) 07/2019 - 08/2006
6	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2017 - 01/2004
6	Ovarian Neoplasms (Ovarian Cancer) 11/2013 - 08/2011
5	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2015
5	Infections 01/2022 - 03/2011
4	Neuroinflammatory Diseases 12/2019 - 09/2011
3	Triple Negative Breast Neoplasms 01/2022 - 01/2020
3	Encephalitis (Encephalitis, Rasmussen) 12/2019 - 05/2007
3	Disease Progression 01/2019 - 04/2010
3	Glioma (Gliomas) 11/2016 - 05/2015
2	Medulloblastoma 01/2022 - 01/2021
2	COVID-19 01/2022 - 01/2021
2	Uveitis 04/2021 - 01/2015
2	Hyperemia 04/2021 - 01/2015
2	Edema (Dropsy) 04/2021 - 01/2015
2	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2018
2	Adenocarcinoma of Lung 03/2021 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2019
2	Central Nervous System Diseases (CNS Diseases) 10/2017 - 09/2014
2	Ischemia 06/2016 - 01/2016
2	Hyperthermia 12/2015 - 04/2014
2	Heart Failure 08/2014 - 08/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2014 - 08/2010
2	Hypertension (High Blood Pressure) 08/2014 - 08/2010
2	Leukemia 01/2013 - 11/2008
2	Adenocarcinoma 01/2013 - 10/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Eye Diseases (Eye Disease) 04/2021
1	Blindness (Hysterical Blindness) 04/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2021

Drug/Important Bio-Agent (IBA)

40	Pharmaceutical PreparationsIBA 01/2022 - 09/2002
22	Poloxamer (Poloxamer 407)IBA 04/2022 - 08/2002
16	MicellesIBA 01/2022 - 12/2004
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 08/2003
10	EnzymesIBA 04/2021 - 08/2010
9	AntioxidantsIBA 04/2021 - 09/2007
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2006
9	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 08/2002
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 08/2014
8	PolymersIBA 11/2013 - 03/2006
7	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2006
7	CatalaseIBA 09/2017 - 01/2011
6	NanogelsIBA 05/2015 - 09/2005
4	LeptinIBA 04/2022 - 04/2010
4	Neuroprotective AgentsIBA 03/2022 - 01/2014
4	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 03/2022 - 01/2014
4	poly(2-oxazoline)IBA 03/2021 - 01/2019
4	ZincIBA 01/2019 - 08/2014
4	CopperIBA 01/2019 - 08/2014
4	Superoxide DismutaseIBA 01/2019 - 08/2014
4	polyethylene glycol polyethyleneimine nanogelIBA 05/2015 - 09/2005
3	Superoxide Dismutase-1IBA 04/2021 - 08/2010
3	Therapeutic UsesIBA 03/2021 - 11/2013
3	Biological ProductsIBA 03/2021 - 08/2011
3	PlatinumIBA 01/2020 - 11/2013
3	SP 1049CIBA 01/2020 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 03/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2014 - 09/2002
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2013 - 09/2005
3	Ethylene Oxide (Oxirane)IBA 05/2010 - 01/2005
2	remdesivirIBA 01/2022 - 01/2021
2	FibrinIBA 04/2021 - 01/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 07/2019 - 05/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2018 - 11/2016
2	Drug CombinationsIBA 01/2018 - 11/2013
2	Liposomes (Liposome)IBA 11/2016 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 05/2015
2	Monoclonal AntibodiesIBA 05/2015 - 05/2015
2	Superoxides (Superoxide)IBA 08/2014 - 08/2010
2	Angiotensin IIIBA 08/2014 - 08/2010
2	methacrylic acidIBA 01/2012 - 02/2010
2	polypropylene glycol (poly(propylene oxide))IBA 05/2010 - 01/2005
2	Adenosine Triphosphate (ATP)IBA 05/2010 - 08/2003
2	Surface-Active Agents (Surfactants)IBA 11/2008 - 12/2004
2	AnthracyclinesIBA 08/2003 - 09/2002
1	Small Cytoplasmic RNAIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	palbociclibIBA 01/2022
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2022
1	sapanisertibIBA 01/2022
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	AerosolsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	NucleosidesIBA 01/2021
1	HhAntag691IBA 01/2021
1	triphosphoric acid (triphosphate)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	resiquimodIBA 01/2020
1	NAD (NADH)IBA 01/2020

Therapy/Procedure

23	Therapeutics 01/2022 - 05/2007
12	Drug Therapy (Chemotherapy) 01/2020 - 08/2003
2	Art Therapy 03/2011 - 05/2007
1	Precision Medicine 01/2022
1	Intravenous Injections 03/2021